UBS Group’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.45K Sell
1,600
-12,711
-89% -$19.4K ﹤0.01% 8145
2025
Q1
$17.6K Buy
+14,311
New +$17.6K ﹤0.01% 7009
2024
Q4
Sell
-19,104
Closed -$53.9K 8908
2024
Q3
$53.9K Buy
+19,104
New +$53.9K ﹤0.01% 5571
2024
Q2
Sell
-427
Closed -$1.84K 8619
2024
Q1
$1.84K Buy
+427
New +$1.84K ﹤0.01% 6864
2023
Q4
Sell
-93
Closed -$422 8385
2023
Q3
$422 Sell
93
-1,414
-94% -$6.42K ﹤0.01% 7358
2023
Q2
$4.67K Sell
1,507
-4,102
-73% -$12.7K ﹤0.01% 6427
2023
Q1
$3.98K Buy
5,609
+5,234
+1,396% +$3.72K ﹤0.01% 7149
2022
Q4
$1.01K Sell
375
-4,284
-92% -$11.6K ﹤0.01% 8795
2022
Q3
$17K Buy
4,659
+4,301
+1,201% +$15.7K ﹤0.01% 6511
2022
Q2
$1K Sell
358
-233
-39% -$651 ﹤0.01% 8863
2022
Q1
$3K Sell
591
-484
-45% -$2.46K ﹤0.01% 8403
2021
Q4
$10K Buy
+1,075
New +$10K ﹤0.01% 7665
2021
Q3
Sell
-873
Closed -$25K 8613
2021
Q2
$25K Sell
873
-847
-49% -$24.3K ﹤0.01% 6022
2021
Q1
$39K Buy
1,720
+881
+105% +$20K ﹤0.01% 5776
2020
Q4
$12K Buy
839
+390
+87% +$5.58K ﹤0.01% 6326
2020
Q3
$7K Sell
449
-651
-59% -$10.1K ﹤0.01% 6245
2020
Q2
$23K Sell
1,100
-478
-30% -$10K ﹤0.01% 5622
2020
Q1
$30K Sell
1,578
-2,476
-61% -$47.1K ﹤0.01% 5313
2019
Q4
$117K Buy
4,054
+1,720
+74% +$49.6K ﹤0.01% 4895
2019
Q3
$119K Sell
2,334
-289
-11% -$14.7K ﹤0.01% 4742
2019
Q2
$208K Buy
2,623
+838
+47% +$66.5K ﹤0.01% 4083
2019
Q1
$118K Buy
1,785
+1,700
+2,000% +$112K ﹤0.01% 4170
2018
Q4
$5K Buy
85
+38
+81% +$2.24K ﹤0.01% 6617
2018
Q3
$4K Sell
47
-550
-92% -$46.8K ﹤0.01% 6650
2018
Q2
$57K Buy
597
+317
+113% +$30.3K ﹤0.01% 4984
2018
Q1
$9K Buy
280
+44
+19% +$1.41K ﹤0.01% 6051
2017
Q4
$9K Buy
236
+30
+15% +$1.14K ﹤0.01% 6121
2017
Q3
$6K Buy
206
+5
+2% +$146 ﹤0.01% 6229
2017
Q2
$8K Buy
+201
New +$8K ﹤0.01% 5965